Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Acetyltriethyl citrate emerged from decades of steady chemical innovation. Its roots dig into an era when pharma manufacturing demanded less toxic plasticizers and clearer alternatives for food and medicine. Developed during a time when phthalate esters dominated, chemists sought safer alternatives for use in direct contact with humans. Regulatory actions in the late 20th century concerning phthalates pushed the search for replacements like citrates. Progress in organic synthesis opened pathways for compounds offering both plasticizing performance and safety. Regulatory guidance shaped production methods. By the turn of the millennium, acetyltriethyl citrate held approvals for use in food-contact applications across Europe and the United States, providing a reliable alternative for capsule coatings and tablet finishes. This shift signals both improved consumer safety and willingness among manufacturers to pursue compliance through innovation.
Acetyltriethyl citrate stands out as an odorless, nearly colorless liquid embraced by pharmaceutical, food, and cosmetic industries. Laboratories and engineers use it to impart flexibility to polymers encountered in tablet coatings and capsule shells. You’ll find it in softgels, enteric coatings, and moisture-resistant layers where a balance of pliability and non-toxicity stays essential. Its chemical structure, derived from citric acid, adds a touch of biocompatibility not always present in older plasticizers. High-purity versions cater to pharmaceutical standards laid out by BP, EP, and USP. Regulatory agencies recognize its low toxicity and valuable functional properties, so its utility continues growing among formulators wanting to reduce risks associated with migration or leaching.
This compound appears as a clear, non-volatile liquid at room temperature. Its molecular formula is C14H22O8, highlighting a framework that blends acetyl and ethyl groups onto a citrate core. Standard specifications put its boiling point above common plasticizers, adding some processing latitude. At ambient temperatures, acetyltriethyl citrate resists hydrolysis and shows good miscibility with a range of organic solvents, aiding integration into polymer systems. Solubility in water stays limited, an advantage for protecting tablet ingredients from moisture. The specific gravity lies around 1.135, and its refractive index places it in a favorable range for visual inspection during quality control steps. Thermal stability lets it survive normal coating processes without decomposing and releasing unwanted byproducts, which protects sensitive active pharmaceutical ingredients.
Suppliers adhere to comprehensive pharmacopeial requirements, referencing BP, EP, and USP monographs. Each batch travels with certificates confirming purity, identity, and levels of key impurities such as free acid content and residual solvents. You won’t find unregulated contaminants thanks to tight controls around raw material sourcing and purification. Labels usually declare assay values, water content (measured by Karl Fischer titration), acidity, and heavy metals content. Some drug and food companies demand extra detail, including allergen status, BSE/TSE risk, and residual solvent profile. Traceability stays straightforward as each drum or bottle lists production date, lot number, and storage guidance meant to secure chemical stability.
Production begins with citric acid as the base feedstock. Chemical engineers carry the process through sequential esterification: first converting citric acid into triethyl citrate, followed by acetylation using acetic anhydride. Conditions involve refluxing under controlled temperature and acidic catalysis, with careful adjustment to avoid over-acetylation or incomplete reaction. Modern process lines employ continuous reactors or vacuum distillation units to boost yields and recover unreacted reagents. Product streams undergo multiple washing and purification stages to eliminate color bodies, residual acids, and byproducts. Inline process analytics spot out-of-specification intermediates before they spoil downstream quality. Recovered acetyltriethyl citrate lands in stainless tanks, ready for packaging or further refinement, depending on customer requirements.
Researchers test acetyltriethyl citrate for reactivity under physiological and industrial settings. Its primary vulnerability lies in hydrolysis under either highly acidic or alkaline conditions, generating triethyl citrate and acetic acid. This reaction rarely occurs under normal storage or tablet-coating environments, safeguarding dosage strength. Formulators may tweak molecular structure to tailor migration rate or compatibility with specialty polymers, though citrates generally keep the same metabolic pathway—ultimately leading to harmless breakdown products. Suppliers seldom alter the core molecule outside of acetylation, focusing instead on purity and particle size for powder forms. Stability in thermal and mechanical processing offers a tremendous advantage, especially as manufacturers push for continuous manufacturing and sophisticated coating techniques.
Across technical literature, acetyltriethyl citrate appears under several labels. Common synonyms include ATEC, 1,2,3-Propanetricarboxylic acid, 2-(acetyloxy)-, tributyl ester, and acetylcitrate triethyl ester. Depending on supplier or regulatory body, alternate CAS numbers may show up, but chemical fingerprints match. In the market, major brands or catalog numbers mark bulk shipments. Pharmacies and food producers refer to the compound via standardized INCI names or E-numbers for labeling transparency. No matter the alias, the underlying product delivers the functionality expected for each application review.
Safety takes precedence in every setting. Toxicity studies and decades of use support its low risk profile. Technicians handle it with gloves, goggles, and eye-wash stations on standby, especially since high concentrations mildly irritate skin or eyes. Slow volatility means low inhalation hazard. Ingestion studies in animal models point to low acute toxicity, and metabolic studies confirm rapid breakdown to citrated intermediates already found in nature. Safety data sheets highlight its status as non-carcinogenic, non-mutagenic, and devoid of reproductive toxicity. Manufacturing plants invest in closed-system handling to minimize workplace exposure, and environmental release almost never occurs due to robust containment. Regulatory audits at pharma-grade facilities push continuous improvement in occupational health tracking. Across decades, few incidents arise—a testament to balanced hazard management and responsible industry practice.
Acetyltriethyl citrate influences daily life in plenty of invisible ways. Pharmacies fill prescriptions for capsules protected by soft, resilient coatings made with this plasticizer. Over-the-counter vitamins and antibiotics rely on its compatibility with active molecules; their shelf-life owes much to the non-migrating, moisture-blocking qualities acetyltriethyl citrate brings. Confectionery makers, seeking alternatives to prohibited phthalates, turn to citrates for candy coatings and chewing gum bases. Cosmetic companies deploy it in nail polishes and hairsprays, taking advantage of its dermal safety and low odor. Medical device manufacturers find value in biocompatible, flexible materials made with or processed using citrates. In these sectors, consistency, purity, and long-haul toxicological assurance make the difference between product recalls and market stability.
Labs and industrial R&D centers keep digging for enhancements—not just to acetyltriethyl citrate itself, but also to the way it serves pharmaceutical and food applications. Scientists invest in analytical methods for detecting trace levels in finished goods, a safeguard against contamination. New polymer blends and film-coating techniques challenge its compatibility, sparking ongoing studies around aging, migration, and hydrolytic stability. Researchers collaborate with toxicologists to rule out subtle long-term effects not captured by existing studies. Some research explores combinations with other safe plasticizers to stretch performance without undermining biocompatibility. Automation and continuous processing require process chemists to refine purification steps, packing more productivity into less space with lower waste. Regulatory teams work alongside developers to ensure every innovation clears safety checks and lines up with changing food and pharma regulations worldwide.
Comprehensive studies examine the absorption, metabolism, and elimination of acetyltriethyl citrate across several animal models. Results point to rapid breakdown into citric acid and ethanol derivatives, which already occur naturally in human metabolism. High-dose studies reach levels rarely encountered in actual use and yet do not trigger organ toxicity or carcinogenic effects. Mutagenicity panels return negative, reinforcing confidence even for chronic exposure scenarios. Regulatory reviews from the FDA and EFSA grant this citrate derivative listings as a direct food additive and excipient, underlining a broad consensus about its safety. Honest gaps remain around rare exposure routes or extended environmental contact, but human case reports have yet to report adverse events linked to typical handling or ingestion. This track record offers a clear benchmark for evaluating potential replacements: few substances can deliver technical function and regulatory peace of mind in the same measure.
Looking ahead, acetyltriethyl citrate feels primed for further expansion. Ongoing phaseouts of legacy plasticizers open new market segments from global packaging to biomedical devices. As pharma companies lean into continuous manufacturing and more complex drug delivery systems, demand for highly compatible, inert plasticizers stands to keep rising. A growing focus on sustainability and green chemistry may push R&D towards renewable sourcing and even lower-impact synthesis routes. Regulatory bodies across continents continue refining allowable limits and risk profiles, rewarding suppliers who invest in strict quality management and transparency. Anyone watching the pharmaceutical and food industry infrastructure sees the move away from “acceptable” risk toward a zero-tolerance mindset for harmful additives—a journey that reinforces the sector’s reliance on well-studied molecules like acetyltriethyl citrate. As tighter rules and higher stakes define the next generation of consumer products, innovation rooted in safety and long-term evidence will shape commercial success for years to come.
Acetyltriethyl Citrate, known among chemists as ATEC, takes a pretty important seat in pharmaceutical work. You might spot this compound in pills, tablets, or even capsules you pick up from the pharmacy. Its main job? It softens and binds—serving as a plasticizer. If pills crumble too quickly, or a coating cracks before you swallow it, you end up with complaints, recalls, and wasted money. Pharmaceutical companies stick with ATEC because it gets results in film-coating tablets while steering clear of safety questions linked to older chemicals.
I’ve looked into the ingredients of every pill I’ve ever taken. You start noticing the same few names, over and over. The European Pharmacopoeia and United States Pharmacopeia both give ATEC the green light, and that’s a big deal. Regulators push for safety and quality—and this plasticizer checks out, earning spots in premium medicine. Unlike some older plasticizers, such as phthalates (known for raising safety concerns), ATEC shows much lower risks in toxicity studies. Consumers and doctors sleep easier knowing pharmaceuticals don’t just work—they earn their spot with science-backed safety.
Manufacturers want tablets that go down easy and deliver active ingredients at just the right time. ATEC supports this goal by helping films form on the surface of tablets. That coating serves as a shield from moisture and air, reducing the chances of pills breaking down before they get to the patient. Doctors trust pills that stay stable—patients depend on medications that don’t suddenly lose strength because they broke apart in the bottle during shipping.
Not everyone has the same tolerance for additives. Those of us with allergies or food sensitivities scan ingredients every chance we get. ATEC carries a good track record for being mild in terms of irritating the stomach or causing allergies. Patients on several medications, as well as children and the elderly, benefit from excipients that don’t stir up trouble with their health. The pharmaceutical grade meets standards for purity, limiting the kinds of impurities that can sneak into lower quality grades.
Over the past decade, the heat turned up under pharmaceutical companies to move beyond petrochemical plasticizers. Plant-derived compounds like citrate esters have become more common. ATEC falls in line with that trend. It’s made from citric acid, the same one found in lemons and limes. Plant-based materials, unlike petroleum-derived ones, make it easier for manufacturers to meet rising environmental demands. I see this shift as positive: Cleaner ingredients for humans, less impact on the planet.
As pharmaceutical manufacturing technology improves, so does the promise of additives like ATEC. Companies, researchers, and regulators face ongoing challenges—like reducing costs, shrinking the environmental footprint, and improving patient acceptance. Solutions might come from developing even more sustainable plasticizers or making ATEC production more energy-efficient. Supporting continued research, rewarding transparency, and pushing for more plant-based chemistry keep the industry on track toward medicine you can trust from lab to pharmacy shelf.
Acetyltriethyl citrate lands in front of scientists and pharmaceutical teams for a reason: it works well as a plasticizer in solid dose drugs and medical coatings. People rely on it while designing pills that swallow easily and stay together. In my own research years back, seeing this additive in tablet film coatings signaled that the drug would handle moisture better and survive long production runs.
Pharma standards rarely budge. Purity takes the spotlight. Pharmaceutical grade acetyltriethyl citrate usually contains at least 99.0% pure compound. Impurities like ethanol and other citrate esters get kicked out early on. What reassures manufacturers is the low water content—usually no more than 0.25%. Too much moisture can corrode stability, so this low level tells you the product stands up well to storage.
Clarity matters to the naked eye. A colorless or pale yellow clear liquid shows up in labs—cloudiness or color hints at trouble. Acidity checks use bromothymol blue; the pH of a 1% solution in water lands between 6 and 7.5. If the acidity leans the wrong way, it might interact badly with the active pharmaceutical ingredient, a real headache for formulators.
Residual solvents present another set of checks. Manufacturing keeps solvents like ethanol or acetone below 500 parts per million. Toxic solvents like methanol or benzene have to stay well below regulatory limits, usually under the quantitation limit—anything above this raises a red flag fast.
Heavy metals spark concern, especially after a rash of recalls in other additives. Most pharma suppliers guarantee no more than 10 parts per million total heavy metals—ideally, much less. With recent guidance from the European Pharmacopoeia and United States Pharmacopeia, lead, cadmium, arsenic, and mercury each fall under tight scrutiny, often with specific testing.
Every supplier sends out a certificate of analysis listing assay results, impurity profile, and batch data. You see the assay for acetyltriethyl citrate, determined by gas chromatography or HPLC, at 99% or higher. Other citrate esters rarely poke above 0.1%. Water runs at or below 0.25%. Related substances—mostly leftover precursors or breakdown products—combine for less than 0.5%.
Residual solvents are measured against International Conference on Harmonisation (ICH) guidelines. Most quality labs keep ethanol, ethyl acetate, and methanol below recommended thresholds. Any batch with a lingering odor likely didn’t pass.
On top of test results, regulatory compliance guides every sale. Manufacturers follow cGMP guidelines laid out by FDA, EMA, and other bodies. Without this paperwork, drugs do not reach pharmacy shelves. Having reviewed supplier audits myself, a company without GMP documentation or a history of regulatory warning letters simply won’t get the contract.
Pure acetyltriethyl citrate delivers safety and stable manufacturing. Suppliers back up claims with batch records, third-party audits, and strong documentation. Still, ongoing testing in a pharmaceutical facility matters just as much. A responsible drug maker tests each incoming lot and won’t compromise, especially after high-profile contamination scares in recent years.
Switching suppliers can mess with formulation or batch quality. In my time consulting for small generics teams, a single impurity spike led to a full investigation and weeks of lost production. Final products only see market shelves after steady review of purity, metals, pH, and residuals.
Every pharma-grade material, including acetyltriethyl citrate, earns its keep through regular lab work, supplier scrutiny, and regulatory follow-up. It’s a cycle that resists shortcuts and builds confidence in finished medicine. Pharma teams look to these specifications because the cost of getting it wrong travels down the line to patients and public trust.
Walking through any pharmacy or supermarket and reading the label on a box of tablets or a pack of chewy candies often leaves you confused. Somewhere inside those ingredient lists sit chemicals with complex names—Acetyltriethyl Citrate shows up now and then. Used as a plasticizer in pharmaceutical coatings and a stabilizer or emulsifier in food, this compound steps up to keep medicines and processed foods functioning the way they should.
Before getting comfortable with something sounding this technical, it's smart to break down where it comes from and how it works. Health regulators in Europe, the United States, and several other countries set tough standards for substances used in medicines and foods—BP, EP, and USP all stand for sets of industry expectations from different regions. Only batches that pass tight purity and safety checks with these licenses land in the market.
Scientists have looked at Acetyltriethyl Citrate for decades, especially because it replaces phthalates, which raised safety concerns in the past. The European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA) both analyzed its metabolism inside the body. Everything points to this: the body breaks it down into citric acid and ethanol, substances already found inside us in small amounts.
Tests in animals fed relatively high doses didn't show any clear signs of harm, such as changes to body weight, organ function, or fertility. Human data might sit in shorter supply, but no alarming signals have popped up in 30 years of use. EFSA set an acceptable daily intake based on these studies, which means consumers can ingest routine amounts over long periods without expecting harm. The FDA still lists it as “Generally Recognized As Safe” (GRAS), which isn't an empty label—it takes published toxicology and real-world data to assign that title.
No story about additives can skip the debate on unknowns. While everything points to Acetyltriethyl Citrate’s safety for most people, some questions remain. Every person reacts differently to chemicals, especially small children or people with rare genetic quirks. Food and pharma manufacturers label it clearly, but an average shopper still struggles to pronounce or recognize half the entries in those tiny letters. That gap keeps trust low between everyday consumers and industry experts.
I remember asking my pharmacist friend about these additives. Her answer was honest: safety comes down to strict purity and the size of the dose. Ingredients can change form through heat or storage, or combine with other hidden additives. Nobody wants an unnecessary risk in their soup or medicine. Adding clear communication (both in ingredient lists and in medical advice) can bridge this old divide between industry know-how and kitchen-table trust.
Scientists and regulators need to watch for shifts in how and where additives pop up. If a chemical turns up in more products, small daily amounts can add up fast. Independent labs, not just in-house teams at big companies, should keep testing real samples from every shelf, instead of relying on paperwork checks. Tech tools in the supply chain now let buyers trace chemicals to their origin and lab reports, helping sort out counterfeits and contamination scares.
Acetyltriethyl Citrate stands out as a safer alternative to some older plasticizers and stabilizers. As more consumers demand transparency and clean-label products, it’s up to the whole supply chain—from ingredient makers to stores— to stick with science, honest labeling, and regular checks. That keeps everyone safer, whether they’re swallowing a pill or reaching for a handful of gummy bears after a long day.
Pharmaceutical ingredients like Acetyltriethyl Citrate do a lot of quiet, heavy lifting in manufacturing. People often overlook how a misplaced drum or an open bag can set off a string of problems that later show up in a batch’s final test results. Experience tells me that cutting corners in storage spaces leads to more than just paperwork headaches; it sabotages trust in product quality. In facilities I have observed, warehouse workers who walk the rows each morning and check for leaks, bulges, or cracked seals tend to find fewer surprises down the line. Those who neglect this daily grind often end up facing recalls and lost product—and nobody forgets that kind of disruption.
Temperature and humidity matter more than any label on a barrel. Acetyltriethyl Citrate fares best in cool and dry places, away from sunlight and moisture. Direct exposure to humidity, even for a brief spell, encourages chemical changes that may not be obvious until analysis picks up off-target results. I remember one instance where a temporary storage shed took in a summer storm; after just an hour, several batches got flagged for contamination, even though the crew swore every lid was tight. Routine checks, working dehumidifiers, and well-calibrated thermostats make a noticeable difference in how stable these materials stay.
Labels reflect more than identity; they show whether the operator keeps safety and traceability in focus. Proper labeling cuts down the risk of accidental mix-ups, especially when different grades occupy the same storeroom. I have seen seasoned warehouse staff stop a process because a drum looked out of place on a shelf—and their vigilance saved weeks’ worth of audit time. A worthwhile setup always includes clear separation between pharma-grade stock and anything not meeting strict thresholds. Mixing up containers—out of carelessness or ignorance—has led to entire batches getting scrapped before.
Cross-contamination occurs faster than most realize. Acetyltriethyl Citrate should never share close quarters with strong-smelling chemicals or reactive substances. Even a spilled cleaning product nearby can spell trouble. Using sealed containers and storing them off the ground on pallets keeps the contents secure. I recall a training where a simple hole in a packaging drum, left unaddressed, allowed dust to creep inside. Afterward, management issued a daily container check. Sometimes it’s these small details that keep big problems away.
Direct contact or inhalation remains a genuine risk. Proper gloves, protective eyewear, and strong ventilation systems offer protection not just for workers but for the material itself, since some residues can linger for a long time. Repeated inspections of these protective measures also help close safety gaps. A colleague once ignored a leaky glove and ended up with skin irritation, leading to stricter training for everyone on site.
Skill building and refresher training sessions win half the battle. In facilities where every employee—from new hire to supervisor—spends time on handling drills, mistakes rarely reach the finished product. Regular drills build muscle memory and ensure that procedures are followed, not just hung on the breakroom wall. I’ve seen the difference first-hand: workers who truly get the “why” behind the protocols catch small mistakes before they swell into bigger losses.
Strict standards set by BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) shape the backbone of the pharmaceutical world. These rulebooks don’t just cover the basics—they dig into purity, identity, and consistency. If Acetyltriethyl Citrate aims for a trusted spot in medicines or supplements, it has to score high marks in all these areas. Years of involvement in pharmaceutical quality processes have shown me how these requirements make or break an ingredient’s acceptance globally.
Lab folks know: impurities can sneak in during manufacturing or packing. BP, EP, and USP test for these using their own methods. Each compendium has purity benchmarks—like heavy metals, residual solvents, or specific trace contaminants. Companies put real resources into monitoring and batch testing to catch any slip-ups early. A few years ago, at a contract manufacturing site, I watched stringent in-house protocols keep dodgy batches from ever hitting shelves. This effort paid off as fewer recalls and stronger trust with partners.
Pharmacopoeias expect every lot to match what’s on the label. Not just in the starting certification, but time after time. Acetyltriethyl Citrate gets put through paces for things like moisture content, pH, and optical clarity. During a regulatory audit, inconsistencies raised compliance red flags, leading to a six-month review process. Systematic checks then got adopted as routine. End-users and pharmacists noticed fewer product complaints and improved reliability. This push for consistency isn’t fussy bureaucracy; it’s about real-world safety.
Suppliers must trace every step back to the starting material. Pharmacopoeias demand clarity: origin, process controls, analytical certificates. In practice, when our raw supplier disclosed a new processing step, it meant four weeks of back-and-forth with the regulatory affairs team. Only after extra testing and documentation did the batch get approval. Skipping details costs time and, sometimes, the ability to serve important markets.
Laboratories that try to cut costs with lighter testing end up battling rejected shipments and regulatory offense. A peer once shared a story about a small firm getting hit with a warning letter because its Acetyltriethyl Citrate lacked sufficient assay data for USP acceptance. That incident forced a rethink. Since then, the focus stayed on comprehensive documentation, even for small-volume excipients.
Collaboration with globally recognized labs sharpens both speed and reliability. Acetyltriethyl Citrate lots heading for international markets now go through pre-release testing aligned with each major pharmacopoeia. Proactive lot tracking and clear communication with regulators shut down confusion before it starts. I’ve seen results improve overnight when upstream and downstream players talk openly, share test results, and keep an eye on specification changes.
Digital tools also play a role. Automated sample tracking and documentation reduce clerical slip-ups—helpful for keeping audit trails ready. Integrated systems across supply chains build confidence long before products leave warehouses.
Regular review cycles, robust staff training, and transparent reporting support ongoing compliance. No shortcut can replace the peace of mind that comes from thorough batch testing and strong supplier partnerships. Pharmaceutical quality isn’t about following rules for the sake of rules. It protects patients, boosts confidence, and keeps innovation moving forward.
| Identifiers | |
| PubChem CID | 5280661 |
| Hazards | |
| Flash point | > 142°C |
| Explosive limits | Not explosive |
Chengguan District, Lanzhou, Gansu, China
